Community-acquired pneumonia: epidemiology, diagnostics and antimicrobal therapy
A.A. Zaitzev
N.N. Burdenko Main Military Clinical Hospital, Moscow
The publication is devoted to actual aspects of epidemiology, diagnostics and treatment of community-acquired pneumonia. Data of its etiology, key points of diagnostics and directions of start antimicrobal therapy are introduced there.
Literature
Чучалин А.Г., Синопальников А.И., Страчунский Л.С., Козлов Р.С., Рачина С.А., Яковлев С.В. Внебольничная пневмония у взрослых. Практические рекомендации по диагностике, лечению и профилактике. М., 2010. 82 с. [Chuchalin A.G., Sinopalnikov A.I., Strachunsky L.S., Kozlov R.S., Rachina S.A., Yakovlev S.V. Community-acquired pneumonia in adults. Practical recommendations concerning diagnostics, treatment and prevention. М., 2010. P.82.] Ewig S., Birkner N., Strauss R., Schaefer E., Pauletzki J., Bischoff H., Schraeder P., Welte T., Hoeffken G. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009;64(12):1062-9. Marrie T.J., Lau C.Y., Wheeler S.L., Wong C.J., Vandervoort M.K., Feagan B.G. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283:749-55. Чучалин А.Г., Синопальников А.И., Козлов Р.С., Авдеев С.Н., Тюрин И.Е., Руднов В.А., Рачина С.А., Фесенко О.В. Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых. М., 2014. Доступно на www.pulmonology.ru. [Chuchaalin A.G., Sinopalnikov A.I., Kozlov R.S., Avdeev S.N., Turin I.E., Rudnov V.A., Rachina S.A., Fesenko O.V. Clinical recommendations for diagnostics, treatment and prevention of severe community-acquired pneumonia in adult patients.М., 2014.] Синопальников А.И., Зайцев А.А. Анализ состояния пульмонологической помощи в вооруженных силах и пути ее улучшения. Воен.-мед. журн. 2008;329(8):31-40. [Sinopalnikov A.I., Zaitsev A.A. Analysis of the condition of pulmonological care for military forces and ways of its improvement. Military-med. journal. 2008;329(8):31-40.] Овчинников Ю.В., Зайцев А.А., Синопальников А.И., Крюков Е.В., Харитонов М.Ю., Чернов С.А., Макаревич А.М. Внебольничная пневмония у военнослужащих: тактика ведения и антимикробная терапия. Воен.-мед. журн. 2016;3:4-14. [Ovchinnikov Ju.V., Zaitzev A.A., Sinopalnikov A.I., Krjukov E.V., Kharitonov M.Ju., Chernov S.A., Makaryevich A.M. Community-acquired pneumonia in military staff: tactics of curation and antimicrobial therapy. Military-med. journal. 2016;3:4-14.] Welte T., Torres A., Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax. 2012;67:71-9. Mandell L.A., Wunderink R.G., et al. Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., Dowell S.F., File T.M., Musher D.M., Niederman M.S., Torres A., Whitney C.G. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Доступно на http://www.thoracic.org/sections/publications/statements/pages/mtpi/idsaats-cap.html. Woodhead M., Blasi F., Ewig S., Garau J., Huchon G., Ieven M., Ortqvist A., Schaberg T., Torres A., van der Heijden G., Read R., Verheij T.J.M. New guidelines for the management of adult lover respiratory tract infections. Clin.Microbiol. Infect. 2011;17(6):1-59. Зайцев А.А. Грипп и тяжелая пневмония: ключевые вопросы диагностики, фармакотерапии, профилактики. Фарматека. 2016;4:21-6. [Zaitzev A.A. Grippe and severe pneumonia: key points of diagnostics, pharmacotherapy, prevention. Pharmateka. 2016;4:21-6.] Louie J., Acosta M., Winter K., Jean C., Gavali S., Schechter R., Vugia D., Harriman K., Matyas B., Glaser C.A., Samuel M.C., Rosenberg J., Talarico J., Hatch D. California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302(17):1896-902. Maruyama T., Fujisawa T., Suga S., Nakamura H., Nagao M., Taniguchi K., Tsutsui K., Ihara T., Niederman M.S. Outcomes and Prognostic Features of Patients With Influenza Requiring Hospitalization and Receiving Early Antiviral Therapy: A Prospective Multicenter Cohort Study. Chest. 2016;149:526-34. Зайцев А.А., Овчинников Ю.В., Кондратьева Т.В. Биологические маркеры воспаления при внебольничной пневмонии. Consilium Medicum. 2014;16(11):36-41. [Zaitzev A.A., Ovchinnikiv Ju.V., Kondratjeva T.V. Biological markers of inflammation in community-acquired pneumonia case.Consilium Medicum. 2014;16(11):36-41.] Bauer T., Ewig S., Marre R., Suttorp N., Welte T. CRB-65 predicts death from community-acquired pneumonia. J. Intern. Med. 2006;260(1):93–101. Charles P., Wolfe R., Whitby M., Fine M.J., Fuller A.J., Stirling R., Wright A.A., Ramirez J.A., Christiansen K.J., Waterer G.W., Pierce R.J., Armstrong J.G., Korman T.M., Holmes P., Obrosky D.S., Peyrani P., Johnson B., Hooy M. SMART-COP: a tool for predicting the need for in-tensive respiratory or vasopressor support in community-acquired pneumonia. Clin. Infect. Dis. 2008;47(3):375-84. Зайцев А.А., Овчинников Ю.В., Кондратьева Т.В. Анализ клинико-диагностических возможностей инструментов оценки тяжести и прогноза внебольничной пневмонии у пациентов молодого возраста из организованных коллективов. Пульмонология. 2014;5:67-72. [Zaitzev A.A., Ovchinnikov Ju.V., Kondratjeva T.V. Analysis of clinical-diagnostical capacities of instruments for community-acquired pneumonia severity and prognosis estimation in young-age patients from organized collectives. Pulmonology. 2014;5:67-72.] Синопальников А.И., Зайцев А.А. Трудная пневмония. Пособие для врачей. Отделение пульмонологии ГВКГ им. Н.Н. Бурденко. М., 2010. 56 с. [Sinopalnikov A.I., Zaitzev A.A. Difficult pneumonia. Manual for physicians. Department of pulmonology of N.N. Burdenko Main Mklitary Clinical Hospital. М., 2010. P. 56.] Jones R., Jacobs M., Sader H. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Int. J. Antimicrob. Agents. 2010;36:197-204. Белькова Ю.А., Рачина С.А., Козлов Р.С. Клинико-экономическая оценка использования цефтаролина фосамила в терапии взрослых госпитализированных пациентов с внебольничной пневмонией пневмококковой этиологии с позиции общества. Клин. микробиология и антимикробная химиотерапия. 2015;17(1):33-52. [Belkova Ju.A., Rachina S.A., Kozliv P.S. Clinical-economical estimation of ceftaroline fosamil in the therapy of adult hospitalized patients with lpneumococcal ethiology community-acquired pneumonia from the positions of society. Clin. microbiology and antimicribial chemotherapy. 2015;17(1):33-52.] Biedenbach D., Badal R., Huang M., Motyl М., Singhal P.K., Kozlov R.S., Roman A.D., Marcella S. In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. Infect. Dis. Ther. 2016;5(3):405. Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance. Доступно на https://www.nice.org.uk/guidance/cg191/chapter/1-Recommendations#community-acquired-pneumonia-2. Boyles T., Brink A., Calligaro G., Cohen C., Dheda K., Maartens G., Richards G.A., van Zyl Smit R., Smith C., Wasserman S., Whitelaw A.C., Feldman C. South African guideline for the management of community-acquired pneumonia in adults. J. Thorac. Dis. 2017;9(6):1469-502. Chidiac C. Antibiothérapie par voie générale dans les infections respiratoires basses de l’adulte. Pneumonie aiguë communautaire. Exacerbations de bronchopneumopathie chronique obstructive. In Médecine et Maladies Infectieuses. 2011;41(5):221-8. Cao B., Huang Y., She D., Cheng Q.J., Fan H., Tian X.L., Xu J.F., Zhang J., Chen Y., Shen N., Wang H., Jiang M., Zhang X.Y., Shi Y., He B., He L.X., Liu Y.N., Qu J.M..Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin. Respir. J. 2017. 20th WHO Model List of Essential Medicines (March 2017).
About the Autors
Andrey A. Zaitzev, MD, chief pulmonologist of N.N. Burdenko Main Military Clinical Hospital of the Ministry of Defence of the RF, Moscow. E-mail: a-zaicev@yandex.ru
Similar Articles